###begin article-title 0
###xml 66 85 66 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Complement Factor H</italic>
###xml 96 105 96 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
Multifactor Effects and Evidence of Potential Interaction between Complement Factor H Y402H and LOC387715 A69S in Age-Related Macular Degeneration
###end article-title 0
###begin p 1
Conceived and designed the experiments: IJ. Performed the experiments: SPS. Analyzed the data: SPS PO SM II IJ. Contributed reagents/materials/analysis tools: SPS GP MX PT PR JH JM TP KK SM II IJ. Wrote the paper: SPS PO GP MX KK SM II IJ.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 16 65 16 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">complement cascade genes and the LOC387715/HTRA1,</italic>
Variants in the complement cascade genes and the LOC387715/HTRA1, have been widely reported to associate with age-related macular degeneration (AMD), the most common cause of visual impairment in industrialized countries.
###end p 3
###begin title 4
Methods/Principal Findings
###end title 4
###begin p 5
###xml 44 53 44 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 84 86 84 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 208 209 208 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 219 221 219 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;9</sup>
###xml 253 254 253 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 264 267 264 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;19</sup>
###xml 303 304 303 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 344 345 344 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 447 472 447 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">complement factor H (CFH)</italic>
###xml 594 603 594 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 605 612 605 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3, CFH</italic>
###xml 779 788 779 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 793 796 793 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 1175 1177 1175 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 1232 1235 1232 1235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 1237 1246 1237 1246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 1251 1253 1251 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
We investigated the association between the LOC387715 A69S and complement component C3 R102G risk alleles in the Finnish case-control material and found a significant association with both variants (OR 2.98, p = 3.75x10-9; non-AMD controls and OR 2.79, p = 2.78x10-19, blood donor controls and OR 1.83, p = 0.008; non-AMD controls and OR 1.39, p = 0.039; blood donor controls), respectively. Previously, we have shown a strong association between complement factor H (CFH) Y402H and AMD in the Finnish population. A carrier of at least one risk allele in each of the three susceptibility loci (LOC387715, C3, CFH) had an 18-fold risk of AMD when compared to a non-carrier homozygote in all three loci. A tentative gene-gene interaction between the two major AMD-associated loci, LOC387715 and CFH, was found in this study using a multiplicative (logistic regression) model, a synergy index (departure-from-additivity model) and the mutual information method (MI), suggesting that a common causative pathway may exist for these genes. Smoking (ever vs. never) exerted an extra risk for AMD, but somewhat surprisingly, only in connection with other factors such as sex and the C3 genotype. Population attributable risks (PAR) for the CFH, LOC387715 and C3 variants were 58.2%, 51.4% and 5.8%, respectively, the summary PAR for the three variants being 65.4%.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 73 90 73 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH and LOC387715</italic>
Evidence for gene-gene interaction between two major AMD associated loci CFH and LOC387715 was obtained using three methods, logistic regression, a synergy index and the mutual information (MI) index.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 298 301 298 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Bird1">[1]</xref>
###xml 539 542 539 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Smith1">[2]</xref>
###xml 544 547 544 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-AgeRelated1">[3]</xref>
###xml 685 704 685 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">complement factor H</italic>
###xml 805 808 805 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Edwards1">[4]</xref>
###xml 809 813 809 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Narayanan1">[19]</xref>
###xml 855 912 855 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715/high temperature requirement factor A-1 (HTRA1)</italic>
###xml 1019 1023 1019 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Rivera1">[11]</xref>
###xml 1025 1029 1025 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Jakobsdottir1">[20]</xref>
###xml 1030 1034 1030 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Weger1">[31]</xref>
###xml 1066 1081 1066 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715/HTRA1</italic>
###xml 1130 1134 1130 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Yang1">[27]</xref>
###xml 1136 1140 1136 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Kanda1">[32]</xref>
###xml 1141 1145 1141 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Tuo1">[34]</xref>
Age-related macular degeneration (AMD [MIM 603075]) is the most common cause of irreversible visual loss in the elderly in the Western world. It is characterized by drusen deposits in its early forms. The late forms are geographic atrophy and exudative AMD, which especially affects central vision [1]. AMD is a complex disease with both genetic susceptibility and environmental risk factors contributing to the disease pathogenesis. Of the environmental risk factors, age and smoking have most consistently been identified as major risks [2], [3]. In the past few years, research into the genetics of AMD has been very successful. An association between the Y402H polymorphism of the complement factor H (CFH [MIM 134370]) gene on chromosome 1 and AMD has been confirmed in several Caucasian populations [4]-[19]. In addition, an association between the LOC387715/high temperature requirement factor A-1 (HTRA1) locus on chromosome 10q and AMD both in Caucasian, and in Japanese and Chinese populations has been found [11], [20]-[31]. Due to the close proximity of LOC387715/HTRA1 and controversial results in functional studies [27], [32]-[34] the true disease-associated variant at this locus has remained so far unknown.
###end p 9
###begin p 10
###xml 56 78 56 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">complement component 3</italic>
###xml 173 177 173 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Yates1">[35]</xref>
###xml 223 227 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Maller1">[36]</xref>
###xml 283 286 283 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 396 400 396 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Walport1">[37]</xref>
Most recently, a common polymorphism (rs2230199) in the complement component 3 (C3 [MIM 120700]) gene of complement cascade was associated with AMD in two case-control sets [35] and confirmed in a large case-control sample [36]. With regard to the previously observed association to CFH this is an interesting observation because CFH is known to inhibit activation of C3 in the complement system [37].
###end p 10
###begin p 11
###xml 34 37 34 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 100 104 100 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Seitsonen1">[16]</xref>
###xml 139 148 139 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 168 173 168 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 200 202 200 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 91 99 <span type="species:ncbi:9606">patients</span>
We have previously shown that the CFH Y402H polymorphism is associated with AMD in Finnish patients [16]. Here we investigated whether the LOC387715 A69S (rs10490924), HTRA1 promoter (rs11200638), or C3 R102G (rs2230199) variants are associated with AMD in the Finnish population. In addition, we compared three different statistical methods to estimate the combined risks and gene-gene and gene-environment interaction of CFH Y402H, LOC387715 A69S, C3 R102G, and smoking to the development of AMD.
###end p 11
###begin title 12
Materials and Methods
###end title 12
###begin title 13
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient material
###end title 13
###begin p 14
###xml 234 238 234 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Seitsonen1">[16]</xref>
###xml 457 461 457 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Seitsonen1">[16]</xref>
###xml 843 851 843 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003833.s002">Table S1</xref>
###xml 904 908 904 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Seitsonen1">[16]</xref>
###xml 4 11 <span type="species:ncbi:9606">patient</span>
###xml 43 51 <span type="species:ncbi:9606">patients</span>
###xml 255 263 <span type="species:ncbi:9606">patients</span>
###xml 478 486 <span type="species:ncbi:9606">patients</span>
###xml 787 794 <span type="species:ncbi:9606">patient</span>
The patient material comprised 332 Finnish patients with AMD attending the Departments of Ophthalmology of Helsinki (n = 201), Oulu (n = 10) and Kuopio (n = 39) University Hospitals, or private offices and outpatient clinics (n = 82) [16]. A total of 151 patients were sporadic cases with no known relatives with AMD and 181 were familial cases with at least one first or second degree relative with AMD. Of the 154 sporadic AMD cases in our previous study [16] we excluded two patients because of genotyping failure and one of the sporadic cases was reported to have a novel AMD case in his family and was thus transferred to the familial group. Of the 181 previous familial cases one from Kuopio University Hospital could not be genotyped because of insufficient sample. Otherwise the patient material was the same as in our previous study (Table S1). We had two control groups, as previously reported [16]: 105 age-matched non-AMD controls with no large drusen and no or minimal focal pigmentary abnormalities and 350 anonymous blood donor controls.
###end p 14
###begin p 15
###xml 654 658 654 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Seitsonen1">[16]</xref>
###xml 35 43 <span type="species:ncbi:9606">patients</span>
###xml 255 263 <span type="species:ncbi:9606">patients</span>
###xml 613 621 <span type="species:ncbi:9606">patients</span>
###xml 716 724 <span type="species:ncbi:9606">patients</span>
In the family members of the index patients, the AMD stage was verified from fundus photographs or angiograms in 45 (60.0%), from the medical records in 28 (37.3%) and from an examination by a retinal specialist belonging to the study group in two of the patients (2.7%). In the rest of the subjects (index cases, sporadic cases and non-AMD controls) the AMD stage was verified from fundus photographs or angiograms in 338 (93.4%), from an examination by a retinal specialist belonging to the study group in four (1.1%) and from medical records in 20 (5.5%) of the subjects. The verification of the AMD status of patients was carried out as described in [16]. Blood samples for genotyping were obtained from all the patients with AMD and control individuals. We chose to use two control groups, 105 ophthalmologically investigated non-AMD controls, and 350 anonymous blood donor controls. Information on smoking was available in only the non-AMD controls. The study was approved by the Ethics Committee of the Helsinki University Eye and Ear Hospital and The Red Cross Blood Transfusion Service, Helsinki, Finland, and performed in accordance with the Declaration of Helsinki. Informed consent was obtained from all of the subjects after explanation of the nature and possible consequences of the study.
###end p 15
###begin title 16
Information on smoking
###end title 16
###begin p 17
###xml 51 63 <span type="species:ncbi:9606">participants</span>
###xml 131 142 <span type="species:ncbi:9606">participant</span>
###xml 503 514 <span type="species:ncbi:9606">participant</span>
Information about the smoking history of the study participants was obtained by telephone. The following data were recorded: Had a participant ever smoked, the ages at which he/she started and quit (if he/she had quit) smoking, as well as the numbers of cigarettes smoked per day during that period. Then, the numbers of pack-years were calculated (cigarettes smoked per dayxyears smoked/20 [cigarettes per pack]). A binary variable, never/ever, was based on the information obtained on whether a study participant had smoked <one pack-year (never-smoker), or >one pack-year (ever-smoker) in his/her lifetime.
###end p 17
###begin title 18
Genotyping
###end title 18
###begin p 19
###xml 29 32 29 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 71 75 71 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Seitsonen1">[16]</xref>
###xml 192 201 192 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 221 245 221 245 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5-GGTGGTTCCTGTGTCCTTCA-3</named-content>
###xml 258 282 258 282 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5-GGGGTAAGGCCTGATCATCT-3</named-content>
###xml 282 286 282 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Yoshida1">[29]</xref>
###xml 292 297 292 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 317 341 317 341 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5-ATGCCACCCACAACAACTTT-3</named-content>
###xml 354 378 354 378 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5-CGCGTCCTTCAAACTAATGG-3</named-content>
###xml 378 382 378 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Yang1">[27]</xref>
###xml 392 394 392 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 413 437 413 437 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5-GGAACAGACCCCTGACAATG-3</named-content>
###xml 450 474 450 474 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5-CTTGTGGTTGACGGTGAAGA-3</named-content>
The genotyping procedure for CFH was described in the previous article [16]. The DNA of the study subjects was amplified by the polymerase chain reaction (PCR) and sequenced using primers for LOC387715 rs10490924 forward 5-GGTGGTTCCTGTGTCCTTCA-3 and reverse 5-GGGGTAAGGCCTGATCATCT-3[29], for HTRA1 rs11200638 forward 5-ATGCCACCCACAACAACTTT-3 and reverse 5-CGCGTCCTTCAAACTAATGG-3[27], and for C3 rs2230199 forward 5-GGAACAGACCCCTGACAATG-3 and reverse 5-CTTGTGGTTGACGGTGAAGA-3. Amplification was performed in a DNA 2720 Thermal Cycler (ABI, Foster city, CA, USA). The polymerase chain reaction conditions were as follows: 5 min at 94degreesC followed by 35 cycles of the denaturation step: 30 s at 94degreesC; the annealing step: 30 s at 59degreesC (rs10490924), 52degreesC (rs 11200638) and 60degreesC (rs2230199); the elongation step: 45 s at 72degreesC; and final extension for 7 min at 72degreesC terminated the reaction after final annealing. Sequencing was performed using cycle sequencing with the Big Dye Terminator kit (version 3.1) supplied by Applied Biosystems (ABI, Foster City, CA, USA), and reactions were run on an ABI 3730 capillary sequencer according to the manufacturer's instructions.
###end p 19
###begin title 20
Statistical analysis
###end title 20
###begin p 21
###xml 340 349 340 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 365 370 365 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
Allele and genotype frequencies were estimated by direct counting. Deviations from Hardy-Weinberg Equilibrium (HWE) were tested with the standard Chi square test separately in cases and controls, to identify possible genotyping problems. No deviations were found (p>0.5 for all tests). The overall success rate in genotyping was 99.5%. The LOC387715 rs10490924 and HTRA1 rs11200638 were found to be in almost perfect LD with each other (D' = 0.99).
###end p 21
###begin title 22
Individual SNPs
###end title 22
###begin p 23
###xml 63 72 63 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 85 90 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 103 105 103 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
The allelic and genotypic associations of the individual loci (LOC387715 rs10490924, HTRA1 rs11200638, C3 rs2230199) were measured by the standard Pearson's Chi square test with one degree of freedom (or Fisher's exact test, where necessary). Marginal odds ratios (OR) and their confidence intervals were estimated for all significantly associated loci to assess the strength of the association. This was carried out with R scripts freely available on the Internet (R Package Epitools (, function odds ratio). Furthermore, population attributable risks (PAR) were estimated with Levin's formula; (100%xproportion of exposedx(OR-1))/(proportion of exposedx(OR-1)+1)), where the proportion of exposed is the frequency the allele or genotype in the blood donor controls).
###end p 23
###begin title 24
Descriptive analyses of GxG interactions
###end title 24
###begin p 25
###xml 29 32 29 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 43 57 43 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715 A69S</italic>
###xml 59 73 59 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715 A69S</italic>
###xml 78 80 78 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 92 95 92 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 106 108 106 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 221 225 221 225 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TTGG</named-content>
###xml 227 231 227 231 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GGCC</named-content>
###xml 233 237 233 237 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TTCC</named-content>
###xml 269 276 269 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003833-t001">Table 1</xref>
###xml 283 291 <span type="species:ncbi:9606">patients</span>
Joint ORs for pairs of loci (CFH Y402H and LOC387715 A69S; LOC387715 A69S and C3 rs2230199; CFH Y402H and C3 rs2230199) were calculated for each 2-locus genotype separately, using the non-risk double homozygote genotype (TTGG, GGCC, TTCC, respectively) as a reference (Table 1). All patients with AMD (n = 332) were compared to blood donor controls (n = 350). The estimation was carried out with the aforementioned R package Epitools.
###end p 25
###begin title 26
###xml 66 67 66 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 119 138 119 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">complement factor H</italic>
###xml 156 158 156 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CC</italic>
###xml 159 161 159 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CT</italic>
###xml 162 164 162 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TT</italic>
###xml 174 183 174 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 200 202 200 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TT</italic>
###xml 203 205 203 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG</italic>
###xml 206 208 206 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GG</italic>
Two-locus odds ratios (OR), 95% confidence intervals (95%CI), and p-values for different genotypic combinations of the complement factor H Y402H (genotypes CC/CT/TT) and the LOC387715 A69S (genotypes TT/TG/GG) polymorphisms.
###end title 26
###begin p 27
###xml 78 82 78 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TTGG</italic>
###xml 105 106 105 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 108 111 108 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 117 118 117 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 120 129 120 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 140 148 <span type="species:ncbi:9606">patients</span>
Eight genotype combinations are compared to the non-risk genotype combination TTGG. The risk alleles are C (CFH) and T (LOC387715). All the patients with AMD (n = 332) are compared to the blood donor controls (n = 350). Note the strong correlation between number of risk alleles present in each two-locus genotype and the estimated odd's ratios.
###end p 27
###begin title 28
Multivariable and interaction analyses
###end title 28
###begin p 29
###xml 619 623 619 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Cordell1">[38]</xref>
###xml 625 629 625 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-North1">[39]</xref>
###xml 781 785 781 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Schmidt1">[21]</xref>
###xml 1030 1033 1030 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 1040 1054 1040 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715 A69S</italic>
###xml 1059 1061 1059 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 1498 1502 1498 1502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-North1">[39]</xref>
###xml 846 854 <span type="species:ncbi:9606">patients</span>
Multivariable logistic regression was used for assessing the relationship between the independent variables and the outcome, estimating the effects of the individual SNPs and covariates (age, sex, smoking), and for dissecting potential gene-gene (GxG) and gene-environment (GxE) interactions in our data. This was carried out with the SPSS Binary logistic regression modeling procedure, in which stepwise backward variable selection procedure was used to screen out the informative covariates from the uninformative. We coded the loci genotypes following the notation presented by Cordell (2002) and North et al (2005) [38], [39], to be able to assess the additive and dominance effects separately, and to compare our numerical results to those obtained by e.g. Schmidt et al 2006 [21], who used the same notation. The data was restricted to the patients and non-AMD controls, since no smoking data was available from the blood donor controls. A series of models, which included the additive and dominance effects for each locus (CFH Y402, LOC387715 A69S and C3 R102G) and environmental effects (sex, smoking) and various GxG, GxE and ExE interactions were fitted to the data. The non-nested models were compared by the means of Akaike's information criterion (AIC), where there is a difference of 2 or more between the AICs of the models including and excluding the term in question, respectively, is taken as evidence of a significantly better fit to the data (as suggested by North et al. 2005) [39]. The existence of dominance effects of individual loci could be ruled out. Thus, at the next stage, when the possible interactions were examined in more detail, only the additive genetic terms (and no dominance terms) were allowed for. This was also necessary in order to keep the number of parameters in the model to a reasonable number.
###end p 29
###begin p 30
###xml 123 127 123 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Zhao1">[40]</xref>
###xml 129 133 129 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-ThorntonWells1">[41]</xref>
###xml 280 284 280 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Rothman1">[42]</xref>
###xml 329 333 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Andersson1">[43]</xref>
###xml 773 777 773 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Andersson1">[43]</xref>
###xml 1200 1210 1200 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003833.s001">Methods S1</xref>
###xml 1212 1216 1212 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Cover1">[44]</xref>
###xml 1418 1419 1418 1419 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1425 1426 1425 1426 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
In addition to the logistic regression approach, which is known to have only modest powers for distinguishing interactions [40], [41], the possible interactions were further sought using two complementary approaches. i) Departure from the additivity model as described by Rothman [42] and implemented by Andersson et al. 2005 () [43]. Rothman has shown that independent risk factors adhere to an additive model where interaction is assessed based on departure from additivity of the disease rates. In this model, biological interaction (that is different from the term biological interaction in cell biology) is assessed using three measures: RERI (the relative excess risk due to interaction), AP (the attributable proportion due to interaction) and S (the synergy index) [43]. A synergy index exceeding 1.00 suggests the presence of at least one shared (metabolic) pathway in the pathogenesis of the disease, where both of the risk factors are required. ii) the mutual information-based statistics for testing interaction between two unlinked loci. Mutual information statistics is designed to measure the dependence between two random variables that can be detected by testing their independence (Methods S1) [44]. Logistic regression analyses and synergy index were calculated either with the SPSS (SPSS Inc., Chicago, Illinois; release 15.0, 2006) statistical software or with R language. We considered two loci G1 and G2, with each locus having two alleles.
###end p 30
###begin title 31
Results
###end title 31
###begin title 32
Individual genetic effects
###end title 32
###begin p 33
###xml 19 28 19 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 46 47 46 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 102 103 102 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 186 187 186 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 197 199 197 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;9</sup>
###xml 236 237 236 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 247 250 247 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;19</sup>
###xml 253 262 253 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003833.s003">Tables S2</xref>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003833.s004">S3</xref>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003833.s005">S4</xref>
###xml 350 352 350 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TT</italic>
###xml 373 375 373 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GG</italic>
###xml 420 421 420 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 431 434 431 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;12</sup>
###xml 450 451 450 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 461 463 461 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 522 523 522 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 533 536 533 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;15</sup>
###xml 552 553 552 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 563 565 563 565 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 668 676 668 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003833.s003">Table S2</xref>
###xml 713 714 713 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 76 83 <span type="species:ncbi:9606">patient</span>
The AMD-associated LOC387715 A69S risk allele T was over-represented in our patient material with the T allele frequency reaching 48% in AMD cases compared to 19.5% in non-AMD controls (p = 3.75x10-9) and 24.7% in blood donor controls (p = 2.78x10-19) (Tables S2, S3 and S4). Both familial and sporadic cases also carried the LOC387715 risk genotype TT more often than the GG genotype (compared to the non-AMD controls: p = 2.73x10-12 ; familial and p = 9.95x10-7; sporadic cases or compared to the blood donor controls : p = 1.35x10-15 ; familial and p = 8.48x10-7; sporadic cases). The difference between the genotype frequencies in the familial and sporadic cases (Table S2) was not statistically significant (p = 0.09).
###end p 33
###begin p 34
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 53 61 53 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003833.s003">Table S2</xref>
###xml 64 73 64 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 89 94 89 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 405 409 405 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Kanda1">[32]</xref>
###xml 411 415 411 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Fritsche1">[33]</xref>
We also analyzed the HTRA1 rs 11200638 polymorphism (Table S2). LOC387715 rs10490924 and HTRA1 rs11200638 are located only 6.1 kb from each other, and correspondingly, we observed only 5 genotypes out of 787 that were different among these two variants. This is inconsistent with perfect LD between the two SNPs. As there is accumulating evidence for LOC387715 A69S to be the actual causal variant in AMD [32], [33], we focused on the association analyses of the LOC387715 gene in this study.
###end p 34
###begin p 35
###xml 4 6 4 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 163 164 163 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 202 203 202 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 214 223 214 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003833.s003">Tables S2</xref>
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003833.s004">S3</xref>
###xml 232 234 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003833.s005">S4</xref>
###xml 268 270 268 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CG</italic>
###xml 363 364 363 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 479 481 479 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GG</italic>
###xml 576 578 576 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GG</italic>
The C3 R102G variant corresponding to the electrophoretic protein variant C3F (fast), was associated with AMD in familial cases when compared to non-AMD controls (p = 0.008) or to blood donor controls (p = 0.039) (Tables S2, S3 and S4). The heterozygous risk genotype CG was also detected more often in familial cases than in non-AMD or blood donor controls with p-values of 0.013 and 0.049, respectively. However, the difference in the frequency of the homozygous risk genotype GG between cases and controls did not to reach statistical significance since there were too few GG cases in our material. However the trend is clear: there seems to be a higher OR for homozygotes than for heterozygous cases.
###end p 35
###begin p 36
###xml 86 89 86 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 96 105 96 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 115 117 115 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
The estimated population attributable risks (PAR) for a carrier of the risk allele of CFHY402H, LOC387715 A69S and C3 R102G (using blood donor controls as a reference group) were 58.2%, 51.4%, and 5.8%, respectively. The joint population attributable risk for the three loci was 65.4%. Since carrying a risk allele in one locus does not exclude also carrying a risk allele in the other locus the summary PAR is less than the sum of the three single PARs. The PAR for smoking was 47.7%, note, however that it had to be estimated using non-AMD controls as a reference group; thus it cannot be interpreted as a true population-wise figure. Also, it is not directly comparable to the gene-wise PAR:s given above due to different reference group used.
###end p 36
###begin title 37
Smoking
###end title 37
###begin p 38
###xml 51 52 51 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 62 64 62 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 164 165 164 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 175 177 175 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
Odds ratio for smoking was 3.22 (95% CI 1.81-6.09, p = 4.69x10-5, non-AMD controls), and the joint OR for the three loci and smoking was 74.3 (95 %CI 10.81-2123.6, p = 1.54x10-7, non-AMD controls).
###end p 38
###begin title 39
Joint OR:s
###end title 39
###begin p 40
###xml 35 54 35 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">complement factor H</italic>
###xml 62 65 62 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Seitsonen1">[16]</xref>
###xml 160 169 160 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 273 274 273 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 284 287 284 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;12</sup>
###xml 364 366 364 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CC</italic>
###xml 368 371 368 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 377 379 377 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TT</italic>
###xml 381 390 381 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 427 432 427 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TTGG,</italic>
###xml 499 506 499 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003833-t001">Table 1</xref>
###xml 542 545 542 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 553 562 553 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 572 574 572 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 606 613 606 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003833-t002">Table 2</xref>
###xml 793 800 793 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003833-t002">Table 2</xref>
We also assessed the joint OR:s of complement factor H Y402H (CFH) polymorphism, previously shown to be associated with AMD in the Finnish population [16], and LOC387715 A69S polymorphism. Joint analysis of ORs for the two variants showed that the risk of AMD was 27-fold (p = 1.66x10-12, blood donor controls) if an individual had both homozygous risk genotypes, CC (CFH) and TT (LOC387715), compared to the non-risk genotype TTGG, respectively, with all the other joint OR:s ranging from 2 to 21 (Table 1). Three-locus risk-allele carrier (CFH Y402H, LOC387715 A69S and C3 R102G) joint OR:s are given in Table 2. The risk of AMD was 18-fold for a carrier of at least one risk allele per susceptibility loci when compared to a non-carrier of risk alleles at any loci in blood donor controls (Table 2).
###end p 40
###begin title 41
###xml 75 76 75 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 154 173 154 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">complement factor H</italic>
###xml 175 178 175 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 191 200 191 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 214 236 214 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">complement component 3</italic>
###xml 238 240 238 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
Three-locus risks (odds ratios [OR], 95% confidence intervals [95%CI], and p-values) for combinations of the risk allele carriers and non-carriers of the complement factor H (CFH) Y402H, the LOC387715 A69S and the complement component 3 (C3) R102G polymorphisms.
###end title 41
###begin p 42
###xml 90 91 90 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 93 96 93 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 99 100 99 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 102 111 102 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 117 118 117 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 120 122 120 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 125 133 <span type="species:ncbi:9606">Patients</span>
Seven combinations are compared to individuals who carry no risk allele. Risk alleles are C (CFH), T (LOC387715) and G (C3). Patients with AMD (n = 332) are compared to blood donor controls (n = 350).
###end p 42
###begin title 43
Interaction analyses
###end title 43
###begin p 44
###xml 67 68 67 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 106 115 106 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 120 123 120 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 178 185 178 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003833-t003">Table 3</xref>
###xml 198 200 198 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 230 231 230 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 299 302 299 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 307 317 307 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715,</italic>
###xml 489 492 489 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 500 509 500 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 519 521 519 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
In the logistic regression modelling, we found highly significant (p<0.001) additive gene effects for the LOC387715 and CFH loci, both having approximately the same effect size (Table 3). Also, for C3 an additive effect was seen (p = 0.007), which was slightly weaker than the individual effects of CFH and LOC387715, but still made the overall fit of the three-locus model statistically significantly better than any two-locus models. No dominance effect could be demonstrated for either CFH Y402H, LOC387715 A69S, or C3 R102G.
###end p 44
###begin title 45
Final model parameters from the logistic regression analyses: the logarithm of odds of being a case rather than a control is explained by genetic effects and their interactions and a set of covariates (for details, see text), from which an automatic stepwise procedure selects the final set of statistically significant variables and estimates their magnitudes.
###end title 45
###begin p 46
Exp(b) is the coefficient corresponding to a one unit change in the explanatory variable. Nagelkerke R Square for the final model was 0.431 (n = 382).
###end p 46
###begin p 47
###xml 38 41 38 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 46 55 46 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 71 72 71 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 162 164 162 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 350 355 350 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003833-g001">Fig 1</xref>
###xml 405 409 405 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Cover1">[44]</xref>
###xml 442 444 442 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 552 560 552 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003833.s006">Table S5</xref>
###xml 647 656 647 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 729 731 729 731 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 797 805 <span type="species:ncbi:9606">patients</span>
Interestingly, an interaction between CFH and LOC387715 was suggested (p = 0.057), with the estimated effect being only a bit smaller than the additive effect of C3 locus alone. With the departure-from-additivity model the attributable proportion due to interaction of the loci was 70% (95%CI 51-89%) and S, the synergy index 3.79 (95%CI 1.82-7.89) (Fig 1). Also, mutual information-based (MI) statistics [44] resulted in a p-value of 1.69x10-6 supporting the results obtained with logistic regression analysis and the departure-from-additivity model (Table S5). No evidence for GxE interaction was obtained with another major susceptibility gene LOC387715 and smoking (p = 0.14) whereas the GxE interaction with sex (p = 1.04x10-6) was shown using MI statistics. Here the higher number of female patients in our study material might affect the result.
###end p 47
###begin title 48
###xml 44 53 44 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 69 72 69 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
Measures of biological interactions between LOC387715 A69S (LOC) and CFH Y402H (CFH).
###end title 48
###begin p 49
###xml 157 161 157 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Andersson1">[43]</xref>
Regression coefficients for the calculations of the estimates were obtained from a separate logistic regression model as described by Andersson et al., 2005 [43]. Figures in parenthesis after measures indicates values with no interaction.
###end p 49
###begin p 50
###xml 117 118 117 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 192 193 192 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 207 209 207 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 219 220 219 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 270 272 270 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 286 287 286 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 319 321 319 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 416 417 416 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 428 435 428 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003833-t003">Table 3</xref>
###xml 666 674 666 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003833.s006">Table S5</xref>
###xml 749 752 749 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3.</italic>
###xml 952 953 952 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 963 965 963 965 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 1120 1121 1120 1121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1355 1357 1355 1357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 1452 1454 1452 1454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CC</italic>
###xml 1515 1516 1515 1516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 1596 1600 1596 1600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3 G</italic>
###xml 1694 1695 1694 1695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 1741 1743 1741 1743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 1833 1835 1833 1835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CC</italic>
###xml 1868 1869 1868 1869 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1912 1913 1912 1913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 2090 2091 2090 2091 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 913 918 <span type="species:ncbi:9606">women</span>
###xml 1009 1014 <span type="species:ncbi:9606">women</span>
###xml 1027 1030 <span type="species:ncbi:9606">men</span>
###xml 1183 1188 <span type="species:ncbi:9606">women</span>
###xml 1800 1805 <span type="species:ncbi:9606">women</span>
No evidence for an independent effect of smoking could be detected in the logistic regression modelling in our data (p = 0.795). Instead, ExE and GxE interactions were suggested: sexxsmoking (p = 0.043) and C3xsmoking (p = 0.086). When combined into a 3-way interaction C3xsexxsmoking (p = 0.016) the 2-way interaction C3xsmoking disappeared. The sexxsmoking interaction term preserved borderline significance (now, p = 0.065) (Table 3). Based on the difference in the AICs of the model including the two 2-way terms vs. one 3-way interaction term proved the latter to be more parsimonious (data not shown). However, synergy index and mutual information statistics (Table S5) failed to show evidence for interaction between neither sex, smoking nor C3. Possible explanations for this complexity in the logistic regression modelling showed up in further stratified analyses, where we found out that i) ever-smoker women had 4.68-fold (95%CI 1.95-14.12, p = 3.60x10-4) risk of AMD when compared to never-smoker women, whereas in men the odd's ratio was smaller (OR = 2.57) and of borderline significance (95%CI 0.99-6.86, p = 0.054). Thus, the effect of smoking was more pronounced in women, which also explains the significance of the sexxsmoking interaction. At the same time it explains why no independent main effect for smoking alone was obtained. ii) C3xsmoking: smoking seemed to have a significant risk-conferring effect on the non-risk genotype CC, but the effect is not that strong (and non-significant) in G-carrying genotypes (although the trend is the same). In the never-smokers, the C3 G allele predisposed to AMD as expected, whereas, interestingly, in ever-smokers the effect of G allele was virtually indistinguishable. iii) C3xsexxsmoking: here we saw the highest OR for ever-smoker women with the non-risk genotype CC (OR = 8.55, [95%CI 2.45-58.46], p = 0.0002), and non-significant effects in G-carrying genotypes (though the trend is the same, that is, smoking predisposed to AMD in all genotypexsex classes, OR:s around 2). Overall, both smoking and carriership of the G allele confers risk for AMD, but the effect could be mediated via a different pathway.
###end p 50
###begin title 51
Discussion
###end title 51
###begin p 52
###xml 42 45 42 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 47 56 47 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 61 64 61 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3)</italic>
###xml 155 158 155 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 163 173 163 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715,</italic>
###xml 417 421 417 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Zhao1">[40]</xref>
###xml 426 434 426 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de facto</italic>
###xml 582 586 582 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Rothman1">[42]</xref>
###xml 588 592 588 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Andersson1">[43]</xref>
###xml 643 647 643 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Despriet1">[45]</xref>
###xml 687 690 687 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 855 859 855 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Baird2">[46]</xref>
###xml 946 949 946 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 1147 1150 1147 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 1155 1165 1155 1165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715.</italic>
###xml 924 937 <span type="species:ncbi:83558">C. pneumoniae</span>
Here we report joint risks of three gene (CFH, LOC387715 and C3) loci, and smoking in AMD. We found tentative evidence for a gene-gene interaction between CFH and LOC387715, the two major susceptibility genes of AMD using three different statistical approaches. The first evidence for interaction was obtained using logistic regression; however, because the power of logistic regression to detect interactions is low [40], it de facto necessitated the use of other, more sensitive methods. Thus we applied the departure-from-additivity model that is based on additive disease rates [42], [43]. This method has also been used by Despriet et al [45] who reported increased risks of AMD in CFH risk genotype carriers with high C-reactive protein serum levels, elevated sedimentation rate (ESR), leucocyte count and smoking and more recently by Baird et al., [46] who demonstrated a GxE-interaction between a pathogenic load of C. pneumoniae and the CFH Y402H in the aetiology of AMD. The third method, mutual information statistics, has not been previously utilized in analyzing risk factors for AMD also suggested strong evidence for interaction of CFH and LOC387715.
###end p 52
###begin p 53
###xml 30 39 30 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 147 151 147 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Rivera1">[11]</xref>
###xml 153 157 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Conley2">[15]</xref>
###xml 159 163 159 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Schmidt1">[21]</xref>
###xml 164 168 164 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Tanimoto1">[24]</xref>
###xml 170 174 170 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Kanda1">[32]</xref>
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Seddon1">[47]</xref>
###xml 181 185 181 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Jakobsdottir2">[51]</xref>
###xml 187 194 187 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003833-t004">Table 4</xref>
###xml 226 229 226 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 240 249 240 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 316 320 316 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Rivera1">[11]</xref>
###xml 364 367 364 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 372 381 372 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 436 440 436 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Jakobsdottir2">[51]</xref>
###xml 692 696 692 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Rivera1">[11]</xref>
###xml 698 702 698 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Conley2">[15]</xref>
###xml 704 708 704 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Schmidt1">[21]</xref>
###xml 710 714 710 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Schaumberg1">[22]</xref>
###xml 716 720 716 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Seddon1">[47]</xref>
###xml 822 826 822 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Zhao1">[40]</xref>
###xml 828 832 828 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-ThorntonWells1">[41]</xref>
###xml 1012 1015 1012 1015 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 1020 1029 1020 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 1149 1158 1149 1158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 1188 1192 1188 1192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Kanda1">[32]</xref>
###xml 1194 1198 1194 1198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Fritsche1">[33]</xref>
###xml 1265 1269 1265 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Giclas1">[52]</xref>
###xml 1512 1516 1512 1516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Nordgaard1">[53]</xref>
###xml 1598 1601 1598 1601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 1610 1619 1610 1619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 69 76 <span type="species:ncbi:9606">patient</span>
The strong association of the LOC387715 A69S with AMD in our Finnish patient material is in agreement with previous results from other populations [11], [15], [21]-[24], [32], [47]-[51] (Table 4). Furthermore, joint risks for CFH Y402H and LOC387715 A69S were also of similar magnitude as observed by Rivera et al., [11]. In addition, the joint additive effect of CFH and LOC387715 has been shown to be strengthened by rare C2 variants [51]. However, discoveries of interactions between these loci (or smoking) have been scarce and they have not been replicated. Thus, we want to point out that most of the analyses of GxG and GxE interaction have been based on logistic regression modelling [11], [15], [21], [22], [47], which according to our present state of understanding is statistically not a very powerful approach [40], [41]. Thus, re-analysis of existing data with more sensitive methods for detecting interaction might, possibly, change the picture a bit. Indeed, a true biological interaction between CFH and LOC387715 would be plausible based on recent cell biological data by Kanda et al. (2007) and Fritsche et al. (2008) showing that LOC387715 is localized to mitochondria [32], [33] and on the earlier evidence that mitochondria activate complement [52]. Interestingly, mitochondrial dysfunction involving altered mitochondrial translation, import of nuclear-encoded proteins, and ATP-synthase activity was suggested in recent proteomics studies on retinal pigment epithelium (RPE) in AMD by age [53]. Further cell and neurobiological studies are warranted to elucidate whether the CFH and the LOC387715 genes indeed belong to a common causative pathway.
###end p 53
###begin title 54
###xml 117 126 117 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
Table summarizes odds ratios (OR) and 95% confidence intervals (CI) of our current study and previous studies on the LOC387715 A69S polymorphism.
###end title 54
###begin p 55
###xml 2 5 2 5 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">het</sub>
###xml 30 32 30 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GT</italic>
###xml 36 38 36 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GG</italic>
###xml 45 48 45 48 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hom</sub>
###xml 66 68 66 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TT</italic>
###xml 72 74 72 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GG</italic>
###xml 76 77 76 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
ORhet refers to comparison of GT to GG and ORhom to comparison of TT to GG. T allele is the risk allele.
###end p 55
###begin p 56
AREDS Age-Related Eye Disease Study
###end p 56
###begin p 57
CHS Cardiovascular Health Study
###end p 57
###begin p 58
OR for individuals having one or both risk alleles (T)
###end p 58
###begin p 59
NEI National Eye Institute
###end p 59
###begin p 60
BMES Blue Mountains Eye Study
###end p 60
###begin p 61
relative risk
###end p 61
###begin p 62
###xml 26 29 26 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 114 116 114 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 118 126 118 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003833.s006">Table S5</xref>
###xml 178 181 178 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 404 408 404 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Despriet1">[45]</xref>
###xml 473 476 473 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 568 572 568 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Robbins1">[54]</xref>
###xml 622 626 622 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Yanbaeva1">[55]</xref>
###xml 686 688 686 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CC</italic>
###xml 692 694 692 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CT</italic>
###xml 707 710 707 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 737 741 737 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Laine1">[56]</xref>
###xml 743 747 743 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Skerka1">[57]</xref>
###xml 816 819 816 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 908 912 908 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Conley2">[15]</xref>
###xml 914 918 914 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-DeAngelis1">[58]</xref>
###xml 919 923 919 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Hughes1">[60]</xref>
A GxE interaction between CFH Y402H and smoking could be detected in our material using MI statistics (p = 8.24x10-4; Table S5). In the Rotterdam study increased risks of AMD in CFH risk genotype carriers with smoking, elevated C-reactive protein serum levels, sedimentation rate (ESR) and leucocyte count were reported using the departure from additivity model (synergy index of 2.38 [95%CI 1.06-5.35]) [45] concordant with our results. An interaction between smoking and CFH would be plausible, since cigarette smoke has been shown to activate the complement system [54]. Smoking also increases serum CRP concentrations [55] and further, impaired binding of C-reactive protein to the CC or CT variants of CFH (Y402H) has been detected [56], [57]. However, in studies using logistic regression analyses smoking and CFH Y402H have consistently been found to be statistically independent risk factors for AMD [15], [58]-[60].
###end p 62
###begin p 63
###xml 160 164 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Conley2">[15]</xref>
###xml 166 170 166 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Ross1">[23]</xref>
###xml 172 176 172 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Wang1">[48]</xref>
###xml 178 182 178 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Hughes1">[60]</xref>
###xml 278 282 278 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Schmidt1">[21]</xref>
###xml 367 371 367 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Tuo1">[34]</xref>
We did not find an interaction between LOC387715 and smoking with any of the three statistical methods used that is in agreement with several previous findings [15], [23], [48], [60], although Schmidt et al. have reported a statistical interaction between LOC387715 and smoking [21] and most recently, an interaction between HTRA1 rs11200638 and smoking was reported [34].
###end p 63
###begin p 64
###xml 30 32 30 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 124 128 124 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Yates1">[35]</xref>
###xml 130 134 130 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Maller1">[36]</xref>
###xml 136 143 136 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003833-t005">Table 5</xref>
###xml 237 240 237 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 251 260 251 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 308 310 308 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 381 388 381 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003833-t002">Table 2</xref>
###xml 391 393 391 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 519 523 519 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Walport1">[37]</xref>
###xml 525 527 525 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 594 597 594 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Hageman1">[7]</xref>
###xml 640 642 640 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 835 837 835 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 837 841 837 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Kew1">[61]</xref>
###xml 843 847 843 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Kew2">[62]</xref>
###xml 910 912 910 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
Here we also demonstrate that C3 seems to have a milder, though a statistically significant effect on AMD, as noted earlier [35], [36] (Table 5). Accordingly, the risk of AMD was 16-fold for a carrier of at least one risk allele at both CFH Y402H and LOC387715 A69S loci, while adding the risk allele of the C3 R102G increased the OR to only 18 using logistic regression analysis (Table 2). C3 plays a crucial role in all the three pathways of the complement system, the classic, the lectin and the alternative pathway [37]. C3 has also been identified in drusen deposits, the hallmarks of AMD [7]. Considering this, the GxG interaction of C3 and CFH Y402H in AMD obtained using MI statistics is reasonable. Furthermore, activation of an alternative pathway of the complement system by cigarette smoke has been shown to be mediated by C3[61], [62]. Considering this it would be reasonable to think that a true C3xsmoking interaction might have exist.
###end p 64
###begin title 65
###xml 117 139 117 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">complement component 3</italic>
###xml 141 143 141 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
Table summarizes odds ratios (OR) and 95% confidence intervals (CI) of our current study and previous studies on the complement component 3 (C3) R102G polymorphism.
###end title 65
###begin p 66
###xml 2 5 2 5 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">het</sub>
###xml 30 32 30 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CG</italic>
###xml 36 38 36 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CC</italic>
###xml 45 48 45 48 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hom</sub>
###xml 66 68 66 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GG</italic>
###xml 72 74 72 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CC</italic>
###xml 76 77 76 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
ORhet refers to comparison of CG to CC and ORhom to comparison of GG to CC. C allele is the risk allele.
###end p 66
###begin p 67
###xml 48 51 48 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 139 142 139 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 171 174 171 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Haines1">[5]</xref>
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Baird1">[13]</xref>
###xml 182 186 182 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Conley2">[15]</xref>
###xml 188 192 188 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Jakobsdottir1">[20]</xref>
###xml 194 198 194 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Schmidt1">[21]</xref>
###xml 207 216 207 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 237 241 237 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Conley2">[15]</xref>
###xml 243 247 243 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Jakobsdottir1">[20]</xref>
###xml 249 253 249 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Schmidt1">[21]</xref>
###xml 276 278 276 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 318 322 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Yates1">[35]</xref>
###xml 377 379 377 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 445 447 445 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CC</italic>
###xml 480 482 480 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 512 516 512 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003833-Schmidt1">[21]</xref>
###xml 861 863 861 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CC</italic>
###xml 871 873 871 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 473 478 <span type="species:ncbi:9606">women</span>
The population attributable risks (PAR) for the CFH Y402H (58.2%) and LOC387715 A69S (51.4%) are in line with other reports where PARs for CFH Y402H range from 43 to 68 % [5], [13], [15], [20], [21] and for LOC387715 A69S from 36 to 57% [15], [20], [21]. Instead, the PAR for C3 R102G in Yates et al. was higher (22%) [35] than what we obtained (5.8%). It is possible that the C3 G allele effect is diluted in our data by the stronger effect of CC genotype in ever-smoking women (C3xsexxsmoking). Schmidt et al. [21] also reported a PAR for smoking which was 20% and thus lower than ours (47.7%), but here it should be noted that we could not estimate the true population-based PAR due to a lack of smoking information in our blood donor controls, and hence ours may be an overestimate. However, the ever-smokers' risk is mediated through the non-risk genotype CC of the C3 gene whereas in the never-smokers the risk effect comes from the reported risk allele warrants further studies.
###end p 67
###begin p 68
In conclusion, analysis of gene-gene and gene-environment interaction of risk factors in AMD benefits from combination of several statistical methods and the available biochemical data.
###end p 68
###begin title 69
Supporting Information
###end title 69
###begin p 70
(1.23 MB DOC)
###end p 70
###begin p 71
Click here for additional data file.
###end p 71
###begin p 72
(0.04 MB DOC)
###end p 72
###begin p 73
Click here for additional data file.
###end p 73
###begin p 74
(0.08 MB DOC)
###end p 74
###begin p 75
Click here for additional data file.
###end p 75
###begin p 76
(0.05 MB DOC)
###end p 76
###begin p 77
Click here for additional data file.
###end p 77
###begin p 78
(0.05 MB DOC)
###end p 78
###begin p 79
Click here for additional data file.
###end p 79
###begin p 80
(0.04 MB DOC)
###end p 80
###begin p 81
Click here for additional data file.
###end p 81
###begin p 82
###xml 233 234 233 234 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</bold>
###xml 13 21 <span type="species:ncbi:9606">patients</span>
###xml 109 116 <span type="species:ncbi:9606">patient</span>
We thank the patients for the participation in the study. We are grateful to Marja Ikonen for collecting the patient samples, and for Janne Pitkaniemi PhD for his invaluable advice and comments concerning the statistics in this study.
###end p 82
###begin title 83
References
###end title 83
###begin article-title 84
An international classification and grading system for age-related maculopathy and age-related macular degeneration. The international ARM epidemiological study group.
###end article-title 84
###begin article-title 85
Risk factors for age-related macular degeneration: Pooled findings from three continents.
###end article-title 85
###begin article-title 86
Risk factors associated with age-related macular degeneration. A case-control study in the Age-Related Eye Disease Study: Age-Related Eye Disease Study report number 3.
###end article-title 86
###begin article-title 87
Complement factor H polymorphism and age-related macular degeneration.
###end article-title 87
###begin article-title 88
Complement factor H variant increases the risk of age-related macular degeneration.
###end article-title 88
###begin article-title 89
Complement factor H polymorphism in age-related macular degeneration.
###end article-title 89
###begin article-title 90
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration.
###end article-title 90
###begin article-title 91
Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration.
###end article-title 91
###begin article-title 92
Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy.
###end article-title 92
###begin article-title 93
Y402H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population.
###end article-title 93
###begin article-title 94
Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk.
###end article-title 94
###begin article-title 95
CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD.
###end article-title 95
###begin article-title 96
Analysis of the Y402H variant of the complement factor H gene in age-related macular degeneration.
###end article-title 96
###begin article-title 97
Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers.
###end article-title 97
###begin article-title 98
CFH, ELOVL4, PLEKHA1 and LOC387715 genes and susceptibility to age-related maculopathy: AREDS and CHS cohorts and meta-analyses.
###end article-title 98
###begin article-title 99
Analysis of variants in the complement factor H, the elongation of very long chain fatty acids-like 4 and the hemicentin 1 genes of age-related macular degeneration in the Finnish population.
###end article-title 99
###begin article-title 100
Polymorphism p.402Y>H in the complement factor H protein is a risk factor for age related macular degeneration in an Italian population.
###end article-title 100
###begin article-title 101
Complement factor H increases risk for atrophic age-related macular degeneration.
###end article-title 101
###begin article-title 102
Complement factor H polymorphism in age-related macular degeneration.
###end article-title 102
###begin article-title 103
Susceptibility genes for age-related maculopathy on chromosome 10q26.
###end article-title 103
###begin article-title 104
Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration.
###end article-title 104
###begin article-title 105
A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors.
###end article-title 105
###begin article-title 106
The LOC387715 polymorphism and age-related macular degeneration: Replication in three case-control samples.
###end article-title 106
###begin article-title 107
A polymorphism of LOC387715 gene is associated with age-related macular degeneration in the Japanese population.
###end article-title 107
###begin article-title 108
HTRA1 variant increases risk to neovascular age-related macular degeneration in Chinese population.
###end article-title 108
###begin article-title 109
HTRA1 promoter polymorphism in wet age-related macular degeneration.
###end article-title 109
###begin article-title 110
A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration.
###end article-title 110
###begin article-title 111
HTRA1 variant confers similar risks to geographic atrophy and neovascular age-related macular degeneration.
###end article-title 111
###begin article-title 112
HTRA1 promoter polymorphism predisposes Japanese to age-related macular degeneration.
###end article-title 112
###begin article-title 113
Association of the HTRA1 gene variant with age-related macular degeneration in the Japanese population.
###end article-title 113
###begin article-title 114
Association of the HTRA1 -625G>A promoter gene polymorphism with exudative age-related macular degeneration in a central European population.
###end article-title 114
###begin article-title 115
A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration.
###end article-title 115
###begin article-title 116
Age-related macular degeneration is associated with an unstable ARMS2 (LOC3877159) mRNA.
###end article-title 116
###begin article-title 117
The HTRA1 promoter polymorphism, smoking and age-related macular degeneration in multiple case-control samples.
###end article-title 117
###begin article-title 118
Complement C3 variant and the risk of age-related macular degeneration.
###end article-title 118
###begin article-title 119
Variation in complement factor 3 is associated with risk of age-related macular degeneration.
###end article-title 119
###begin article-title 120
Complement, first of two parts.
###end article-title 120
###begin article-title 121
###xml 88 94 <span type="species:ncbi:9606">humans</span>
Epistasis: What it means, what it doesn't mean, and statistical methods to detect it in humans.
###end article-title 121
###begin article-title 122
Application of logistic regression to case-control association studies involving two causative loci.
###end article-title 122
###begin article-title 123
Test for interaction between two unlinked loci.
###end article-title 123
###begin article-title 124
###xml 25 30 <span type="species:ncbi:9606">human</span>
Genetics, statistics and human disease: analytical retooling for complexity.
###end article-title 124
###begin article-title 125
Epidemiology. An Introduction.
###end article-title 125
###begin article-title 126
Calculating measures of biological interaction.
###end article-title 126
###begin article-title 127
Elements of information theory.
###end article-title 127
###begin article-title 128
Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration.
###end article-title 128
###begin article-title 129
Gene-environment interaction in progression of AMD: the CFH gene, smoking and exposure to chronic infection.
###end article-title 129
###begin article-title 130
Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration.
###end article-title 130
###begin article-title 131
The LOC387715 polymorphism, inflammatory markers, smoking, and age-related macular degeneration. A population-based case-control study.
###end article-title 131
###begin article-title 132
###xml 38 60 38 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1, LOC387715/ARMS2</italic>
###xml 66 69 66 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
Joint effects of polymorphisms in the HTRA1, LOC387715/ARMS2, and CFH genes on AMD in a Caucasian population.
###end article-title 132
###begin article-title 133
The LOC387715 gene, smoking, body mass index, environmental associations with advanced age-related macular degeneration.
###end article-title 133
###begin article-title 134
C2 and CFB genes in age-related maculopathy and joint action with CFH and LOC387715.
###end article-title 134
###begin article-title 135
###xml 46 51 <span type="species:ncbi:9606">human</span>
In vitro activation of complement by isolated human heart subcellular membranes.
###end article-title 135
###begin article-title 136
Mitochondrial proteomics of the retinal pigment epithelium at progressive stages of age-related macular degeneration.
###end article-title 136
###begin article-title 137
Complement activation by cigarette smoke.
###end article-title 137
###begin article-title 138
Systemic effects of smoking.
###end article-title 138
###begin article-title 139
Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein.
###end article-title 139
###begin article-title 140
Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration.
###end article-title 140
###begin article-title 141
Cigarette smoking, CFH, APOE, ELOVL4, and risk of neovascular age-related macular degeneration.
###end article-title 141
###begin article-title 142
Independent effects of complement factor H Y402H polymorphism and cigarette smoking on risk of age-related macular degeneration.
###end article-title 142
###begin article-title 143
Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking.
###end article-title 143
###begin article-title 144
Cigarette smoke can activate the alternative pathway of complement in vitro by modifying the third component of complement.
###end article-title 144
###begin article-title 145
Characterization of the third component of complement (C3) after activation by cigarette smoke.
###end article-title 145
###begin p 146
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 146
###begin p 147
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was funded by grants from the Paivikki and Sakari Sohlberg Foundation, Hel-sinki, Finland; The Mary and Georg Ehrnrooth Foundation, Helsinki, Finland; The Eye and Tissue Bank Foundation, Helsinki, Finland; The Eye Foundation, Helsinki, Finland; The Evald and Hilda Nissi Foundation, Vaasa, Finland; The Academy of Finland, Hel-sinki, Finland; Helsinki University Central Hospital Research Funds (TYH5117, TYH6233), Helsinki, Finland; and National Institutes of Health (EY11515). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors do not have any financial interests to disclose.
###end p 147

